These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6610082)

  • 1. [A change in the expression of histocompatibility antigens could lead to autoimmunity].
    Pujol-Borrell R; Bottazzo GF; Feldmann M
    Med Clin (Barc); 1984 Apr; 82(13):594-5. PubMed ID: 6610082
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell tolerance: models for clinical application to allergy and autoimmunity.
    Schad VC
    Chem Immunol; 1994; 58():193-205. PubMed ID: 8011152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aberrant expression of HLA-DR antigens and autoimmune phenomenon in endocrine diseases].
    Gutiérrez C; Fernández-Cruz E
    Rev Clin Esp; 1986 Apr; 178(6):255-8. PubMed ID: 3487815
    [No Abstract]   [Full Text] [Related]  

  • 4. [Autoimmune diseases].
    Gross R
    Wien Med Wochenschr; 1985 Nov; 135(21):538-9. PubMed ID: 3878632
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.
    Bottazzo GF; Pujol-Borrell R; Hanafusa T; Feldmann M
    Lancet; 1983 Nov; 2(8359):1115-9. PubMed ID: 6138647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The HLA histocompatibility system].
    Wadgymar A
    Rev Invest Clin; 1984; 36(3):287-92. PubMed ID: 6393263
    [No Abstract]   [Full Text] [Related]  

  • 7. [Autoimmune processes in chronic adrenal insufficiency].
    Okeanova TA; Marova EI; Gincherman EZ
    Sov Med; 1983; (11):48-53. PubMed ID: 6229047
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of autoimmune diseases with intravenous gammaglobulin.
    Gelfand EW
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):127-33. PubMed ID: 1387255
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histocompatibility antigens and autoimmune diseases].
    Pérez González J; Sarriá A; Legido A; Ventura P; Larrad L
    An Esp Pediatr; 1985 Aug; 23(2):112-6. PubMed ID: 3864387
    [No Abstract]   [Full Text] [Related]  

  • 10. First-class culprit. An autoimmunity theory meets with resistance.
    Rennie J
    Sci Am; 1992 Apr; 266(4):24-5. PubMed ID: 1566030
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR on T and non-T mononuclear leukocytes.
    J Exp Med; 1980 Aug; 152(2 Pt 2):137s-139s. PubMed ID: 6447742
    [No Abstract]   [Full Text] [Related]  

  • 13. The implications for childhood leukemia of infection with adenovirus.
    Dorak MT
    Trends Microbiol; 1996 Feb; 4(2):60-3. PubMed ID: 8820568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA complex and immune response in health and disease.
    Quaranta V
    Clin Physiol Biochem; 1983; 1(2-5):173-8. PubMed ID: 6597048
    [No Abstract]   [Full Text] [Related]  

  • 15. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
    Fu Y; Nathan DM; Li F; Li X; Faustman DL
    J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon.
    Wang D; Levasseur-Acker GM; Jankowski R; Kanny G; Moneret-Vautrin DA; Charron D; Lockhart A; Swierczewski E
    Clin Exp Allergy; 1997 Mar; 27(3):306-14. PubMed ID: 9088657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors.
    Ito Y; Nieda M; Uchigata Y; Nishimura M; Tokunaga K; Kuwata S; Obata F; Tadokoro K; Hirata Y; Omori Y
    J Immunol; 1993 Nov; 151(10):5770-6. PubMed ID: 8228261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-class II antibody treatment in autoimmune diseases.
    Boitard C
    Immunol Ser; 1993; 59():279-93. PubMed ID: 8461393
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular pathomechanism of autoimmune encephalitis].
    Tabira T; Nishizawa M
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1283-90. PubMed ID: 2356331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.